Molecular Profiles' investment makes HME (bio)available for clients
Molecular Profiles has invested in hot melt extrusion (HME) and nano milling capabilities citing client demand for improving the bioavailablity of drugs.
Archives for April 7, 2014
EU and Aus to share resources in 'time-saving' orphan drug approval
The EMA and TGA have agreed to share full assessment reports related to marketing authorisations of orphan drug in the latest regulatory collaboration intended to save time and resources.
Team culturing cancer APIs says tech can make other plant derived drugs
Enzyme experts trying to make the anticancer APIs vincristine and vinblastine with engineered cell lines say the technology could be used to produce a wide range of plant-derived drug actives including alkaloids like morphine.
Debiopharm selects CRO Evotec for early cancer drug discovery deal
CRO Evotec AG will help Debiopharm identify and develop novel compounds with the potential to treat multiple forms of solid tumours and leukaemias with defined genetic alterations under a collabortation announced today.
Bristol-Myers Squibb extends deal with DKSH in SE Asia
Bristol-Myers Squibb has extended its partnership with DKSH to provide commercialization and distribution services across Southeast Asia.
Fiocruz to help make pediatric formulation of bitter schistosomiasis drug
A consortium developing treatments for children infected by parasitic worms has signed up Brazilian drugmaker Fiocruz as a formulation and manufacturing partner to support upcoming clinical trials.
EU law: public database for trial transparency
Companies running clinical trials will have to use an online portal to stay on the right side of the latest EU legislation on data transparency.